TrialVascular health and risk management2022

Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT).

Elizabeth do Espirito Santo Cestario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.